Evidence map›Paper›PMID 28515294›Full record

ArticleJournal of virology2017

Deletion of the Vaccinia Virus B1 Kinase Reveals Essential Functions of This Enzyme Complemented Partly by the Homologous Cellular Kinase VRK2.

Annabel T Olson, Amber B Rico, Zhigang Wang, Gustavo Delhon, Matthew S Wiebe

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Molecular neuropsychiatry · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Annabel T OlsonNebraska Center for Virology, University of Nebraska, Lincoln, Nebraska, USA.
Amber B RicoNebraska Center for Virology, University of Nebraska, Lincoln, Nebraska, USA.
Zhigang WangNebraska Center for Virology, University of Nebraska, Lincoln, Nebraska, USA.
Gustavo DelhonSchool of Veterinary Medicine and Biomedical Sciences, University of Nebraska, Lincoln, Nebraska, USA.
Matthew S WiebeNebraska Center for Virology, University of Nebraska, Lincoln, Nebraska, USA mwiebe@unl.edu.
University of Nebraska–Lincoln · US

Funding

Nebraska Center for VirologyP30GM103509 · NIGMS · UNIVERSITY OF NEBRASKA LINCOLN · PI WOOD, CHARLES · 2012 to 2014
$3.3M
Mechanism of the Antiviral Activity of BAF Against Poxvirus and HSV-1 InfectionR01AI114653 · NIAID · UNIVERSITY OF NEBRASKA LINCOLN · PI WIEBE, MATTHEW S · 2015 to 2019
$1.8M
Comparative Virology Research Training ProgramT32AI125207 · NIAID · UNIVERSITY OF NEBRASKA LINCOLN · PI WEAVER, ERIC A · 2016 to 2020
$844k
NIAID NIH HHS R01 AI114653NIAID NIH HHS T32 AI125207NIGMS NIH HHS P30 GM103509
6 · The paper itself

Abstract

The vaccinia virus B1 kinase is highly conserved among poxviruses and is essential for the viral life cycle. B1 exhibits a remarkable degree of similarity to vaccinia virus-related kinases (VRKs), a family of cellular kinases, suggesting that the viral enzyme has evolved to mimic VRK activity. Indeed, B1 and VRKs have been demonstrated to target a shared substrate, the DNA binding protein BAF, elucidating a signaling pathway important for both mitosis and the antiviral response. In this study, we further characterize the role of B1 during vaccinia infection to gain novel insights into its regulation and integration with cellular signaling pathways. We begin by describing the construction and characterization of the first B1 deletion virus (vvΔB1) produced using a complementing cell line expressing the viral kinase. Examination of vvΔB1 revealed that B1 is critical for the production of infectious virions in various cell types and is sufficient for BAF phosphorylation. Interestingly, the severity of the defect in DNA replication following the loss of B1 varied between cell types, leading us to posit that cellular VRKs partly complement for the absence of B1 in some cell lines. Using cell lines devoid of either VRK1 or VRK2, we tested this hypothesis and discovered that VRK2 expression facilitates DNA replication and allows later stages of the viral life cycle to proceed in the absence of B1. Finally, we present evidence that the impact of VRK2 on vaccinia virus is largely independent of BAF phosphorylation. These data support a model in which B1 and VRK2 share additional substrates important for the replication of cytoplasmic poxviruses.

Indexed as

Gene DeletionHost-Pathogen InteractionsVirus ReplicationAnimalsCell LineDNA ReplicationHumansProtein Serine-Threonine KinasesVaccinia virusViral ProteinsProtein Serine-Threonine KinasesVB1R protein, Vaccinia virusViral ProteinsVRK2 protein, humanB1RBAFBANF1poxvirusesprotein kinasesvacciniaVRK2

Identifiers

PMID28515294
PMCPMC5512240
OpenAlexW2614417421

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.